Ajanta Pharma Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AJANTA PHARMA LTD
AJANTA PHARMA LTD has seventy-two approved drugs.
There are six tentative approvals on AJANTA PHARMA LTD drugs.
Summary for Ajanta Pharma Ltd
| US Patents: | 0 |
| Tradenames: | 59 |
| Ingredients: | 58 |
| NDAs: | 72 |
Drugs and US Patents for Ajanta Pharma Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ajanta Pharma Ltd | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | TABLET;ORAL | 218564-001 | Jul 1, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ajanta Pharma Ltd | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 213651-002 | Apr 9, 2020 | AB2 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ajanta Pharma Ltd | THEOPHYLLINE | theophylline | TABLET, EXTENDED RELEASE;ORAL | 218401-002 | Mar 26, 2025 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Ajanta Pharma Ltd | ARIPIPRAZOLE | aripiprazole | TABLET;ORAL | 206174-004 | Sep 12, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
